Comparison of the effects of the irreversible aromatase inhibitor exemestane with atamestane and MDL 18962 in rats with DMBA-induced mammary tumours
- 30 September 1991
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (9) , 1145-1150
- https://doi.org/10.1016/0277-5379(91)90313-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Novel Irreversible Aromatase InhibitorsAnnals of the New York Academy of Sciences, 1990
- Clinical Use of Aromatase Inhibitors: Current Data and Future PerspectivesJournal of Enzyme Inhibition, 1990
- 6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): A new irreversible aromatase inhibitorJournal of Steroid Biochemistry, 1988
- Differential Responses of Sex Steroid Target Tissues of Rats Treated with 4-Hydroxyandrostenedione*Endocrinology, 1988
- Endocrine properties of 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304), a new irreversible aromatase inhibitorJournal of Steroid Biochemistry, 1987
- Biological characterization of 10-(2-propynyl) estr-4-ene-3,17-dione (MDL 18,962), an enzyme-activated inhibitor of aromataseSteroids, 1987
- Aromatase inhibitors and benign prostatic hyperplasiaJournal of Steroid Biochemistry, 1986
- 1-methyl-1,4-androstadiene-3,17-dione (SH 489): Characterization of an irreversible inhibitor of estrogen biosynthesisJournal of Steroid Biochemistry, 1986
- Biochemical and Endocrine Properties of a Mechanism-Based Inhibitor of AromataseEndocrinology, 1984
- The Effect of an Aromatase Inhibitor, 4-Hydroxy-4-Androstene- 3,17-Dione, On Estrogen-Dependent Processes in Reproduction and Breast Cancer11Endocrinology, 1977